ClinicalTrials.Veeva

Menu

Effect of Bed Bathing Methods on VRE Colonization in ICU Patients

Ö

Özkan Kasap

Status

Completed

Conditions

Vancomycin-Resistant Enterococcus

Treatments

Procedure: Bed Bath
Device: Disposable antibacterial bed bath wipes
Drug: Chlorhexidine gluconate 4%

Study type

Interventional

Funder types

Other

Identifiers

NCT07364435
2024-188

Details and patient eligibility

About

This randomized controlled trial aims to compare the effects of two different bed bathing methods on vancomycin-resistant Enterococcus (VRE) colonization in adult intensive care unit patients. A total of 210 patients were randomly assigned to receive either daily whole-body bathing with 4% chlorhexidine gluconate solution or daily bed bathing using disposable antibacterial body wipes. VRE colonization was monitored using skin swab cultures collected on days 7, 14, and 21. The results of this study may contribute to infection prevention strategies in intensive care units by identifying effective hygiene practices for reducing VRE colonization.

Full description

This study was designed as a randomized controlled trial conducted in the general intensive care units of a tertiary care hospital. Adult patients meeting the inclusion criteria were randomly assigned to one of two parallel groups. The experimental group received daily whole-body bed bathing with a 4% chlorhexidine gluconate solution, while the control group received daily bed bathing using disposable antibacterial body cleansing wipes.

Randomization was performed to ensure comparable baseline characteristics between the groups. VRE colonization was assessed through skin swab cultures obtained at baseline and subsequently on days 7, 14, and 21. The primary outcome of the study was the rate of VRE colonization over time. Secondary analyses included the evaluation of patient-related factors such as age, length of stay, body mass index, and previous VRE history.

All procedures were performed by trained nursing staff according to standardized protocols. The study was conducted following ethical approval obtained from the institutional ethics committee, and informed consent was obtained in accordance with ethical standards. The findings of this study aim to support evidence-based infection control practices in intensive care nursing.

Enrollment

210 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients aged 18 years and older
  • Patients admitted to the intensive care unit
  • Expected ICU stay of at least 48 hours
  • Patients requiring daily bed bathing

Exclusion criteria

  • Known hypersensitivity to chlorhexidine
  • Extensive skin lesions or burns
  • Patients colonized or infected with VRE at ICU admission
  • Pregnancy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

210 participants in 2 patient groups

4% Chlorhexidine Gluconate Bed Bath
Experimental group
Description:
Participants receive daily whole-body bed bathing using a 4% chlorhexidine gluconate solution as part of the bed bathing procedure.
Treatment:
Drug: Chlorhexidine gluconate 4%
Procedure: Bed Bath
Disposable Antibacterial Bed Bath Wipes
Active Comparator group
Description:
Participants receive daily bed bathing using disposable antibacterial body cleansing wipes.
Treatment:
Device: Disposable antibacterial bed bath wipes

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems